U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook

Name: U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The veterinary active pharmaceutical ingredients manufacturing market in the United States is expected to reach a projected revenue of US$ 5,279.0 million by 2033. A compound annual growth rate of 5.8% is expected of the United States veterinary active pharmaceutical ingredients manufacturing market from 2025 to 2033.

U.S. veterinary active pharmaceutical ingredients manufacturing service type outlook (Revenue, USD million, 2021-2033)
- In House
- Contract Outsourcing
  - Contract Development
    - Preclinical Development
    - Clinical Development
  - Contract Manufacturing
U.S. veterinary active pharmaceutical ingredients manufacturing synthesis type outlook (Revenue, USD million, 2021-2033)
- Chemical Based API
- Biological API
- HPAPI
U.S. veterinary active pharmaceutical ingredients manufacturing therapeutic category outlook (Revenue, USD million, 2021-2033)
- Antiparasitics
- Anti-infectives
- NSAIDs
- Others
U.S. veterinary active pharmaceutical ingredients manufacturing animal type outlook (Revenue, USD million, 2021-2033)
- Companion Animals
- Production Animals

U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook

Sign up - it's easy, and free!